RNF139 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.02419999650871E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.64663999999703E-05 |
Normal-vs-Stage2 |
8.36450000000211E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.105900E-02 |
Stage1-vs-Stage2 |
7.378000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.627400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.649000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.24050000003007E-07 |
Normal-vs-AfricanAmerican |
2.130200E-01 |
Normal-vs-Asian |
6.30069999999483E-05 |
Caucasian-vs-AfricanAmerican |
2.434200E-01 |
Caucasian-vs-Asian |
8.778000E-01 |
AfricanAmerican-vs-Asian |
2.728800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.739620E-03 |
Normal-vs-Female |
2.26469999975443E-07 |
Male-vs-Female |
4.694600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.336200E-03 |
Normal-vs-Extreme_Weight |
3.377300E-04 |
Normal-vs-Obese |
6.520800E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.295800E-01 |
Normal_Weight-vs-Obese |
3.168600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.033000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.334800E-01 |
Normal-vs-Age(41-60Yrs) |
6.784000E-04 |
Normal-vs-Age(61-80Yrs) |
1.97376999999666E-05 |
Normal-vs-Age(81-100Yrs) |
1.881520E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.615400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.453000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.053600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.898000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.298200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.609400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.804600E-01 |
Normal-vs-Grade 3 |
1.836010E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.731000E-01 |
Grade 2-vs-Grade 4 |
2.804600E-01 |
Grade 3-vs-Grade 4 |
1.836010E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.77859999950236E-07 |
Normal-vs-N1 |
6.776100E-02 |
N0-vs-N1 |
2.642600E-01 |
|
|